Mr. DiPiano is Managing General Partner and co-founder of NewSpring Capital, a leading provider of private equity capital managing over $1bn across four distinct strategies. He is a General Partner of the Firm’s dedicated growth equity funds and serves as a member of the investment committee of all NewSpring Capital funds. Prior to joining NewSpring Capital, Mr. DiPiano was a serial entrepreneur and investor. He led or co-led the investment into six companies in the business services, healthcare and information technology industries. During that time, he was affiliated with Safeguard Scientifics (NYSE:SFE) and their related funds. Prior to 1996, he spent six years as a division CEO and board member of Chemical Lehman Corporation. Mr. DiPiano started his career in 1980 with Baxter Healthcare Corporation (NYSE: BAX) where he held numerous executive positions. He currently serves on the boards of Open Road, FirstBest, FemmePharma, Message Systems, Mobiquity and The University City Science Center, where he also serves on the Investment Committee. Mr. DiPiano has a B.S. from Penn State University and an MBA from Stern School at New York University.